Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Injection site reactions Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications
In normal human biology, GLP-1 is just one component of a coordinated signaling system involving multiple hormones, microbiome signals, and nerve pathways
In unadjusted analyses, the risk of all-cause mortality and recurrence did not differ significantly between GLP-1RA and SGLT2 inhibitor use, although adjusted models suggested lower hazards with GLP-1RA use
A woman with Prader-Willi syndrome gives birth to a healthy baby girl
Ziltivekimab, a new monoclonal antibody directed against IL-6, has been specifically designed for patients with atherosclerosis and high cardiovascular risk and is being evaluated both in patients with atherosclerosis and CKD and in patients with HFpEF [20,21,22]
Our team is dedicated to providing personalized and effective solutions, and we are excited to offer the magic of Semaglutide to our clients